View daily earnings, market cap, volume and coverage →
agent-data.centorprat.workers.dev · agent-data.centorprat.workers.dev · AI Models & Inference
| Day · UTC | Earned | Gross volume | Refunds | Observed transfers | Market cap | Revenue coverage |
|---|---|---|---|---|---|---|
| 2026-10-26 | — | — | — | — | — | none |
| 2026-10-25 | — | — | — | — | — | none |
| 2026-10-24 | — | — | — | — | — | none |
| 2026-10-23 | — | — | — | — | — | none |
| 2026-10-22 | — | — | — | — | — | none |
| 2026-10-21 | — | — | — | — | — | none |
| 2026-10-20 | — | — | — | — | — | none |
View daily history → · UTC days; today's figures are partial.
Give it conditions, drugs or sponsors. For each it queries ClinicalTrials.gov and composes ONE landscape brief: counts by phase and status, recruiting-now, top sponsors, interventions and countries, median enrollment and recent starts. Keyless and agent-callable. Up to 3 items per call; failed lookups are not charged.
Quoted from x402 Bazaar · source record · read 2026-10-26
No settled payment on record. Earnings for this service are unknown — not zero. The source counts 4 calls in 30 days, which at the published price is roughly $0.12 of activity. Activity is not revenue; no charge has been reconciled for it.
A payment rail is where the provider asks to be paid. It is not proof that anything was paid through it. See evidence levels.
{
"body": {
"conditions": [
"pancreatic cancer"
]
},
"bodyType": "json",
"method": "POST",
"type": "http"
}
{
"example": {
"items": [
{
"analyzed": 200,
"byPhase": [
{
"count": 92,
"name": "NA"
},
{
"count": 63,
"name": "PHASE2"
},
{
"count": 57,
"name": "PHASE1"
},
{
"count": 6,
"name": "PHASE3"
},
{
"count": 3,
"name": "PHASE4"
},
{
"count": 2,
"name": "EARLY_PHASE1"
}
],
"byStatus": [
{
"count": 80,
"name": "COMPLETED"
},
{
"count": 32,
"name": "RECRUITING"
},
{
"count": 30,
"name": "UNKNOWN"
},
{
"count": 19,
"name": "TERMINATED"
},
{
"count": 14,
"name": "WITHDRAWN"
},
{
"count": 13,
"name": "ACTIVE_NOT_RECRUITING"
},
{
"count": 8,
"name": "NOT_YET_RECRUITING"
},
{
"count": 1,
"name": "SUSPENDED"
},
{
"count": 1,
"name": "ENROLLING_BY_INVITATION"
},
{
"count": 1,
"name": "NO_LONGER_AVAILABLE"
},
{
"count": 1,
"name": "AVAILABLE"
}
],
"matchedTotal": 5109,
"medianEnrollment": 48,
"note": "Distributions are over the 200 analysed trials (a sample of 5109 matches; raise maxTrialsPerQuery for full coverage).",
"query": "pancreatic cancer",
"queryType": "condition",
"recentlyStarted": 5,
"recruitingOrUpcoming": 40,
"sponsorClasses": [
{
"count": 150,
"name": "OTHER"
},
{
"count": 38,
"name": "INDUSTRY"
},
{
"count": 9,
"name": "NIH"
},
{
"count": 3,
"name": "OTHER_GOV"
}
],
"topCountries": [
{
"count": 85,
"name": "United States"
},
{
"count": 29,
"name": "China"
},
{
"count": 19,
"name": "France"
},
{
"count": 11,
"name": "South Korea"
},
{
"count": 10,
"name": "Spain"
},
{
"count": 10,
"name": "United Kingdom"
},
{
"count": 9,
"name": "Italy"
},
{
"count": 8,
"name": "Germany"
},
{
"count": 8,
"name": "Canada"
},
{
"count": 7,
"name": "Australia"
}
],
"topInterventions": [
{
"count": 17,
"name": "Gemcitabine"
},
{
"count": 8,
"name": "gemcitabine hydrochloride"
},
{
"count": 7,
"name": "Oxaliplatin"
},
{
"count": 5,
"name": "Nab-paclitaxel"
},
{
"count": 5,
"name": "fluorouracil"
},
{
"count": 4,
"name": "Bevacizumab"
},
{
"count": 4,
"name": "Placebo"
},
{
"count": 4,
"name": "Nivolumab"
},
{
"count": 4,
"name": "Cisplatin"
},
{
"count": 4,
"name": "Capecitabine"
}
],
"topSponsors": [
{
"count": 8,
"name": "National Cancer Institute (NCI)"
},
{
"count": 4,
"name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"
},
{
"count": 4,
"name": "Pfizer"
},
{
"count": 4,
"name": "M.D. Anderson Cancer Center"
},
{
"count": 3,
"name": "West China Hospital"
},
{
"count": 3,
"name": "Minia University"
},
{
"count": 3,
"name": "Fox Chase Cancer Center"
},
{
"count": 2,
"name": "OHSU Knight Cancer Institute"
}
]
}
]
},
"type": "json"
}
Examples are the provider's own, not a call we made.
One row per statement. “Verified” means we checked it ourselves and the finding is quoted. “Provider claim” means we read it in the provider's own record. “Not found” is a statement about our search, not proof of absence.
| Statement | Status | What we found | Source | Checked |
|---|---|---|---|---|
| Endpoint | Provider claim |
https://agent-data.centorprat.workers.dev/tools/clinical-trials-intelligence
EvidenceAls Resource-URL im Bazaar-Eintrag geführt. |
api.cdp.coinbase.com | 2026-10-26 |
| Input output | Provider claim |
Request/response examples published with the listing
EvidenceBeispiel-Ein- und -Ausgabe stammen aus dem Bazaar-Eintrag des Anbieters. |
api.cdp.coinbase.com | 2026-10-26 |
| Payment | Provider claim |
3 rails: Base, Polygon, Solana · payee 0x8d38D6026cf3A9805DE9c5F0611ceE95B532B120
EvidenceAus den `accepts`-Einträgen: Netzwerk, Asset, Empfängeradresse und Betrag. Die Adresse ist die Grundlage der späteren On-Chain-Zuordnung; sie ist noch nicht durch eine eigene 402-Antwort bestätigt. |
api.cdp.coinbase.com | 2026-10-26 |
| Pricing | Provider claim |
0.03 USDC per call
EvidenceAtomic amount 30000 = 0.03 USDC per call on Base. 3 payment options published. Netzwerk: Base, Polygon, Solana. |
api.cdp.coinbase.com | 2026-10-26 |
| Protocol | Provider claim |
x402 (HTTP 402 payment challenge)
EvidenceIm x402 Bazaar als zahlungspflichtige HTTP-Ressource gelistet (x402Version 2, Typ http). |
api.cdp.coinbase.com | 2026-10-26 |
| Provider | Provider claim |
agent-data.centorprat.workers.dev
EvidenceDie Ressource wird unter diesem Host im x402 Bazaar geführt; die Angaben stammen vom Anbieter. |
api.cdp.coinbase.com | 2026-10-26 |
| Usage | Verified |
4 calls / 2 unique payers in the last 30 days
EvidenceSource-reported usage from Coinbase x402 Bazaar, read on 2026-10-26. Letzter Aufruf laut Quelle: 2026-10-25T17:21:49.853Z. Aufrufe sind kein Umsatz. |
api.cdp.coinbase.com | 2026-10-26 |
We have not called this endpoint yet. Until we do, everything above is what the source published — no more.
Web scraping / URL fetch: retrieve any web page and return clean, LLM-ready markdown text. Strips boilerplate, ads, and navigation. Stealth HTTP client bypasses common bot blocks. Cheapest way to read a webpage.
Get OpenAI-compatible inference from many models at market prices via Surplus Intelligence.
Structured evaluation with TypeSafe's Jev (System One) model. Send any state plus typed questions — noul (true/false), choice (pick one), or score (ordinal scale) — and get back calibrated probabilities and confidence fo...
On-demand AI responses backed by autonomous ICP canisters. Submit a prompt, get an answer — redundant infrastructure, pay-per-query, no account required.
Chosen by category and by whether we have measured them, not by who pays us. A sponsored placement in this list is labelled as such.